Spink J, Cohen J, Evans TJ (1995) The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase activation by nuclear factor-B (*)
Dermatology and Therapy, 11 (4), 1385
Answer: Yes, of course
2022;377:eabq1841
Antibodies were primaries rabbit anti--arrestin-1/2 (D24H9, Cell Signaling, 1/1000), rabbit anti-SNAP tag (New England Biolabs, 1/500), mouse anti--tubulin (T5168, Sigma, 1/1000), rabbit anti--actin (4970, Cell Signaling, 1/1000), and mouse anti-GAPDH (6C5, Merck, 1/10,000)
This advancement allows investigation of patient-specific disease mechanisms, therapeutic responses, and drug sensitivities ( (i) drug development process and (ii) precision medicine approach ( Drug Screening and Toxicology Testing